Biventricular Assistance for Chronic Heart Failure

Heart Failure Burden

Over 23 million people worldwide live with heart failure. This number increases by more than 500.000 each year. Many patients progress to advanced stages of the disease where symptoms like shortness of breath at rest or fatigue occur. Frequent hospitalizations are necessary. The number of patients by far exceeds the currently available treatment options.


AdjuCor develops new extravascular devices for individualized biventricular augmentation of the failing heart. The company’s mission is to enable such patients to regain quality of life, by a reduction of associated symptoms and an improvement of physical constitution.

Management Team

We are a group with multidisciplinary expertise.

Dr. Stephen Wildhirt

Professor of Cardiothoracic Surgery
CEO, Co-Founder

Dr. Andreas Maier

CTO Mechanics

Dr. Johannes Clauss

CTO Electronics

Dr. Hamman deVaal

Biomedical Engineer

Advisory Board

AdjuCor continuously receives expert advice for the improvement of their heart failure devices.

Prof. Stephan Schüler MD, PhD, FRCS

Consultant Cardiac Surgeon
Head of Department of Cardio Thoracic Surgery
Head of Mechanical Circulatory Support
Freeman Hospital
Newcastle upon Tyne, UK

Prof. Ulrich A. Stock MD

Professor of Cardiothoracic Surgery
Consultant Cardiothoracic Surgeon
Royal Brompton and Harefield NHS Trust
Harefield Hospital
Harefield, Middlesex, UK

Prof. Axel Bauer

Medizinische Klinik I
Leitung Campus Innenstadt
Klinikum der Universität

AdjuCor uses imaging data to respect the specific individual anatomy of each patient’s heart. It results in enhanced functionality and efficiency of the cardiac assist devices. The implants are positioned outside the blood stream with no need for device dependent anticoagulation. This results in the reduction of risk for stroke and bleeding, both being the predominant causes for re-hospitalization.

Cooperative Projects / Partner

AdjuCor benefits from various cooperative R&D projects with partners from academia and industry.

Prof. Michael Gee

Mechanical High Performance Computing Group
Technische Universität München

Prof. Eckhard Wolf

Molecular Animal Breeding and Biotechnology
Ludwig-Maximilians-Universität München
Dept. of Veterinary Sciences

Prof. Katja Schenke Layland
Dr. Svenja Hinderer

Dept. of Women's Health
Research Institute for Women's Health
University of Tübingen

Prof. Dr.-Ing. Christina Schindler

Munich University of Applied Sciences
Department of Applied Natural Sciences and Mechatronics

Public Support and Funding

Within the cooperative projects with their scientific partners, AdjuCor is funded and supported by State of Bavaria, the German Ministry of Economic Affairs and Energy and the European Union.


Unsolicited applications are welcome.

AdjuCor is a high-tech medical technology company. We are continuously looking for specialists from medicine, biotechnology, mechanical and electronic engineering that are interested in the research and development of medical device technology.

Contact / Imprint

If you have any questions or need information, please call or email us:

AdjuCor GmbH

Managing Director: Professor Dr. med. Stephen Wildhirt
HRB: 183620
UId: DE 271301817